Preferred practice pattern changes

Comment

Eric L Singman. Ophthalmology. 2004 Mar.

. 2004 Mar;111(3):610-1; author reply 611.

doi: 10.1016/j.ophtha.2003.12.038.

No abstract available

Comment on

Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review.
Stanford MR, See SE, Jones LV, Gilbert RE. Stanford MR, et al. Ophthalmology. 2003 May;110(5):926-31; quiz 931-2. doi: 10.1016/S0161-6420(03)00083-6. Ophthalmology. 2003. PMID: 12750091

Unusual toxoplasmic chorioretinitis in advanced age: a diagnostic problem.
Mataftsi A, Fragkou A, Vezyri E, Topouzis F, Diza E, Dimitrakos SA. Mataftsi A, et al. Semin Ophthalmol. 2011 Jan;26(1):4-6. doi: 10.3109/08820538.2010.541315. Semin Ophthalmol. 2011. PMID: 21275597
Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
McLeod R, Khan AR, Noble GA, Latkany P, Jalbrzikowski J, Boyer K; Toxoplasmosis Study Group. McLeod R, et al. Pediatr Infect Dis J. 2006 Mar;25(3):270-2. doi: 10.1097/01.inf.0000202070.59190.9a. Pediatr Infect Dis J. 2006. PMID: 16511396
Clinical features of toxoplasmic retinochoroiditis in patients with acquired immunodeficiency syndrome.
Pivetti-Pezzi P, Accorinti M, Tamburi S, Ciapparoni V, Abdulaziz MA. Pivetti-Pezzi P, et al. Ann Ophthalmol. 1994 May-Jun;26(3):73-84. Ann Ophthalmol. 1994. PMID: 7944160 No abstract available.
Controversies in ocular toxoplasmosis.
Wakefield D, Cunningham ET Jr, Pavesio C, Garweg JG, Zierhut M. Wakefield D, et al. Ocul Immunol Inflamm. 2011 Feb;19(1):2-9. doi: 10.3109/09273948.2011.547157. Ocul Immunol Inflamm. 2011. PMID: 21250922 Review.
Treating ocular toxoplasmosis: current evidence.
Stanford MR, Gilbert RE. Stanford MR, et al. Mem Inst Oswaldo Cruz. 2009 Mar;104(2):312-5. doi: 10.1590/s0074-02762009000200027. Mem Inst Oswaldo Cruz. 2009. PMID: 19430659 Review.